Surgery Partners Lowers Growth Forecast as Volumes, Payer Mix Shift
Investors hammered the company’s shares on the “prudent” guidance, even though CEO Eric Evans said he doesn’t see the slowdown being a long-term trend
Read More
Privacy Rules Are Tightening, Again. Here’s How Your Healthcare Marketing Can Embrace Compliance to Thrive
How can healthcare providers contend with a regulatory environment that has never been more fragmented? Here are three lessons on why privacy is your competitive advantage. The post Privacy Rules Are Tightening, Again. Here’s How Your Healthcare Marketing Can Embrace Compliance to Thrive appeared first on MedCity News.
Regeneron Gets Landmark FDA Approval for First Gene Therapy for Hearing Loss
Regeneron Pharmaceuticals’ Otarmeni is now approved for treating hearing loss from an ultra-rare genetic mutation found in an estimated 50 newborns per year. While Regeneron will offer this gene therapy for free, the approval came with a rare pediatric disease priority review voucher that the company can sell for hundreds of millions of dollars. The…
Little Tracking, Wide Variability Permeate the Teams Tasked With Stopping School Shootings
Max Schachter wanted to be close to his son Alex on his birthday, July 9, so he watched old videos of him. “It put a smile on my face to see him so happy,” Schachter said. Alex would have turned 21 that day, six years after he and 16 other children and staff at Marjory…
MedCity FemFwd: Addressing the Maternal Health Crisis with Dr. Bayo Curry-Winchell
In this episode, we’re joined by Dr. Bayo Curry-Winchell, founder of Beyond Clinical Walls and medical director of urgent care clinics at Saint Mary’s Regional Medical Center. She discusses the role unconscious bias plays in maternal health disparities and ways the healthcare industry can address the maternal health crisis. The post MedCity FemFwd: Addressing the…
How to increase patient engagement
Patient engagement still has a long way to go, and hinges on patient access. According to the 2024 Experian State of Patient Access survey, just 28% of patients feel access has improved since the previous years. However, more than half (51%) feel it has remained static. Today’s patients are tech-savvy and have access to more…
La vejez en soledad, así vive un número histórico de estadounidenses
Gerri Norington, de 78 años, nunca quiso estar sola al envejecer. Pero su primer matrimonio acabó en divorcio y su segundo marido murió hace más de 30 años. Cuando una relación de cinco años llegó a su fin en 2006, se encontró sola, y así sigue desde entonces. “Echo de menos tener un compañero con…
Why Some Hospitals Are Betting on Midstream Health to Help Eliminate Waste
Midstream Health is taking a bit of a different approach to healthcare AI by focusing on reducing hospitals’ costs rather than boosting their revenue. The startup uses AI to identify savings opportunities across fragmented spending data, which helps health systems like Mount Sinai and CommonSpirit quickly improve their purchasing decisions. The post Why Some Hospitals…
Case study: Weill Cornell increases collections by $15M with Collections Optimization Manager
“Our call strategies did not yield the desired outcomes, and we recognized the need for additional data to better support our goal. We were also mindful of the potential risk of staff burnout and the impact it could have on overall performance.” —Carey Lawrence, Revenue Cycle Administrator Customer Service and Self-Pay Collections, Weill Cornell Medicine…
J&J’s Growth Strategy in Lung Cancer Borrows From Its Experience in Multiple Myeloma
Johnson & Johnson has projected its lung cancer drug Rybrevant could achieve $5 billion in peak revenue. At the recent ASCO annual meeting, J&J executive Joshua Bauml explained his company’s strategy for this drug in lung cancer and beyond. The post J&J’s Growth Strategy in Lung Cancer Borrows From Its Experience in Multiple Myeloma appeared…